There are more than 18 million cases of severe sepsis worldwide each year, and 750000 cases of sepsis in the United States each year, and this number is increasing at a rate of 1.5 to 8.0 per cent per year. Sepsis means a dangerous condition with a high mortality rate. About 14,000 people die from its complications every day in the world, and about 215000 people die in the United States every year. According to foreign epidemiological investigations, the mortality rate of sepsis has exceeded that of myocardial infarction and has become the main cause of death of non-cardiac patients in intensive care units. In recent years, although anti-infection treatment and organ function support technology has made great progress, the mortality rate of sepsis is still as high as 30% ~ 70%. Sepsis treatment costs high, medical resources consumption is huge, seriously affect the quality of human life, has caused great threat to human health.
The rapid targeted drug sensitivity solution for sepsis of microbial mass spectrometry + sepsis rapid targeted drug sensitivity analyzer + bacterial liquid preparation instrument given by TahoBiology can give a drug sensitivity test report within 2 hours. It is revolutionary in the field of sepsis.
